SG Americas Securities LLC lifted its stake in Integer Holdings Corporation (NYSE:ITGR – Free Report) by 127.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,951 shares of the medical equipment provider’s stock after acquiring an additional 25,732 shares during the period. SG Americas Securities LLC owned 0.13% of Integer worth $4,748,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in ITGR. KLP Kapitalforvaltning AS raised its holdings in Integer by 7.1% during the third quarter. KLP Kapitalforvaltning AS now owns 7,500 shares of the medical equipment provider’s stock worth $775,000 after purchasing an additional 500 shares in the last quarter. Cerity Partners LLC increased its position in shares of Integer by 344.2% during the 3rd quarter. Cerity Partners LLC now owns 118,468 shares of the medical equipment provider’s stock valued at $12,241,000 after purchasing an additional 91,797 shares during the period. North Growth Management Ltd. raised its stake in shares of Integer by 5.1% in the 3rd quarter. North Growth Management Ltd. now owns 103,000 shares of the medical equipment provider’s stock worth $10,593,000 after buying an additional 5,000 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in shares of Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 238 shares during the period. Finally, Salomon & Ludwin LLC bought a new position in Integer during the third quarter valued at about $26,000. Institutional investors and hedge funds own 99.29% of the company’s stock.
Integer Trading Up 1.9%
NYSE ITGR opened at $84.39 on Friday. The firm’s 50 day moving average price is $73.30 and its two-hundred day moving average price is $94.38. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $146.36. The stock has a market cap of $2.96 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 0.77 and a beta of 0.78.
Integer declared that its board has authorized a share buyback program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.
Insiders Place Their Bets
In other Integer news, Director Cheryl C. Capps bought 1,600 shares of the company’s stock in a transaction dated Thursday, November 6th. The shares were bought at an average price of $66.70 per share, for a total transaction of $106,720.00. Following the acquisition, the director directly owned 11,702 shares of the company’s stock, valued at approximately $780,523.40. This trade represents a 15.84% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Payman Khales purchased 3,127 shares of Integer stock in a transaction dated Thursday, October 30th. The stock was bought at an average cost of $64.94 per share, with a total value of $203,067.38. Following the completion of the transaction, the chief executive officer directly owned 22,865 shares of the company’s stock, valued at $1,484,853.10. This represents a 15.84% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders purchased 5,843 shares of company stock worth $384,771. Insiders own 2.16% of the company’s stock.
More Integer News
Here are the key news stories impacting Integer this week:
- Neutral Sentiment: Lead-plaintiff deadline set for February 9, 2026 — multiple notices remind investors who bought ITGR between July 25, 2024 and October 22, 2025 to file if they want to seek lead-plaintiff status. Berger Montague investor reminder
- Negative Sentiment: Multiple law firms (Levi & Korsinsky, Berger Montague, Schall, BFA, Gross, Glancy, Bernstein Liebhard, Bronstein, ClaimsFiler and others) have publicized a securities class action against Integer alleging securities-fraud-related claims tied to a prior share-price drop. These coordinated notices increase the probability of consolidated litigation, media scrutiny and potential settlement exposure. Levi & Korsinsky notice
- Negative Sentiment: Allegations include violations of §§10(b) and 20(a) and Rule 10b-5; class period and alleged misstatements are specified in several firm filings — this frames the legal theory and the types of damages plaintiffs will seek, which could raise defense costs and settlement risk. Schall Law Firm notice
- Negative Sentiment: Firms emphasize prior “significant stock drop” and encourage loss claims — if plaintiffs demonstrate class-wide losses, settlement pressures increase; the timing of filings, discovery and potential injunctions could add near-term volatility. PR Newswire Levi & Korsinsky
Analysts Set New Price Targets
A number of equities research analysts have weighed in on ITGR shares. Citigroup upped their price target on shares of Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Piper Sandler cut their target price on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Truist Financial raised their target price on shares of Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Raymond James Financial reaffirmed an “outperform” rating and issued a $95.00 price target (down previously from $143.00) on shares of Integer in a report on Friday, October 24th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Integer in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Integer has an average rating of “Hold” and an average price target of $98.38.
Check Out Our Latest Report on Integer
Integer Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
- Five stocks we like better than Integer
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
